Tag Archives: Charles Berkman

The SVP, GC & Sec of Ligand Pharma is Exercising Options

Today it was reported that the SVP, GC & Sec of Ligand Pharma (NASDAQ: LGND), Charles Berkman, exercised options to buy 2,000 LGND shares at $14.47 a share, for a total transaction value of $28.94K. Following Charles Berkman’s last LGND